Aashka Hospitals Limited
BBSE:AASHKA101.00
INR
-2.90
(-2.79%)
ISIN
INE0EAX01014
Return %
Stock
S&P 500
1Y
17.44
14.20
3Y
103.51
81.12
5Y
121.98
68.34
Capital Structure
INR
•
in mil. unless spec.Working Capital
INR
•
in mil. unless spec.Growth Rates
INR
•
in mil. unless spec.Semi-annual Revenue
INR
•
in mil. unless spec.Semi-annual Earnings Per Share
INR
•
in mil. unless spec.Semi-annual Dividends Per Share
INR
•
in mil. unless spec.Company Description
- CEO
- Bipinchandra D Shah
- Full Time Employees
- 235
- Sector
- Health services
- Industry
- Hospital/Nursing management
- Address
- Between Sargasan & Reliance Cross Road Gandhinagar GU India 382421
- IPO Date
- Sep 1, 2021
- Website
- aashkahospitals.in
- Similar Companies
- Business
- Aashka Hospitals Limited, a multi-speciality tertiary care hospital, operates from Gandhinagar, Gujarat, India, where it was incorporated in 2012 and maintains its headquarters between Sargasan and Reliance Cross Road, Sargasan. The company provides comprehensive inpatient and outpatient healthcare services across a 150-bed facility, including 65 ICU beds equipped with intelligent ventilators, bi-phasic AED and pacing defibrillators, modular touch screen multipara monitoring systems, and centralized gas supply; it features class 100 modular cardiac operating theatres, four dedicated super-speciality OTs with laminar airflow and HEPA filters, a state-of-the-art flat panel Cath Lab, CT scan, pneumatic transfer system, and software-driven administration. Core services encompass anaesthesiology, nephrology with dialysis and transplantation, neurology and neurosurgery covering epilepsy, stroke, Parkinson's, movement disorders, and cerebrovascular diseases, cardiology and cardiothoracic vascular surgery, orthopaedics and joint replacement, oncology including medical and surgical variants, obstetrics and gynaecology with fertility treatments like IVF and IUI, pulmonology, gastroenterology and endoscopy, ophthalmology, burns and plastic surgery, critical care and emergency medicine, dentistry, dermatology and cosmetology, ENT, physiotherapy and rehabilitation, interventional radiology, internal medicine and geriatrics, paediatrics and neonatology, pain management, psychiatry, and urology; the facility supports over 4,900 surgeries annually and serves more than 65,000 patients, including 18,000 inpatients and 47,000 outpatients, with an in-house pharmacy and health packages for preventive care. The hospital primarily serves patients in Gujarat and India, focusing on urban and tier-II markets with 24/7 emergency services and advanced diagnostics. Recent developments include the appointment of Mr. Jigar Kanakchandra Trivedi as an additional non-executive independent director effective November 1, 2024, regularized by shareholders on February 27, 2025, following the resignation of Mr. Hiteshkumar Ramanlal Shah on January 28, 2025; partnerships with ManipalCigna Health Insurance and MAGMA General Insurance to expand coverage; sustained profitability with net profit rising to INR 326.61 lakhs for the fiscal year ended March 31, 2025 from INR 235.78 lakhs the prior year amid revenue from operations of INR 2,264.68 lakhs; and a workforce of 229 permanent employees as of that period, with no subsidiaries, associates, or joint ventures.